GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CDP-323 | CDP323
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Zaurategrast (CDP-323) is a small molecule inhibitor of α4-containing integrin complexes that was developed by Celltech [3]. It was intended as a new oral drug treatment for multiple sclerosis [2]. Zaurategrast has the same mechanism of action as the approved MS therapeutic natalizumab. Zaurategrast is an ester prodrug whose active entity is CT7758 [1].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| IUPAC Name  | 
| (2S)-2-[(2-bromo-3-oxospiro[3.5]non-1-en-1-yl)amino]-3-[4-(2,7-naphthyridin-1-ylamino)phenyl]propanoic acid | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 9166 | zaurategrast | 
| Synonyms  | 
| CDP-323 | CDP323 | 
| Database Links  | |
| CAS Registry No. | 455264-31-0 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL4303708 | 
| GtoPdb PubChem SID | 440816856 | 
| PubChem CID | 10186367 | 
| Search Google for chemical match using the InChIKey | KYHVWHYLKOHLKA-FQEVSTJZSA-N | 
| Search Google for chemicals with the same backbone | KYHVWHYLKOHLKA | 
| Search PubMed clinical trials | zaurategrast | 
| Search PubMed titles | zaurategrast | 
| Search PubMed titles/abstracts | zaurategrast | 
| UniChem Compound Search for chemical match using the InChIKey | KYHVWHYLKOHLKA-FQEVSTJZSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | KYHVWHYLKOHLKA-FQEVSTJZSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                           
                                                                           Zaurategrast (links to external site) Cat. No. HY-70073 |